Table 6. Open in new tab Univariate and... | Oxford Academic

Table 6.

Open in new tab

Univariate and multivariate Cox analysis for determining factors associated with OPIs

Varaibles	HR	95% CI	P-value	HR	95% CI	P-value
Age	1.08	1.02–1.14	.01	1.08	1.01–1.14	.02
Female	2.08	0.76–5.76	.15
ECD	1.13	0.40–3.20	.82
eGFR on day 0	0.94	0.87–1.01	.09	0.94	0.86–1.03	.15
Transplant department	1.15	0.41–3.25	.79
Interval between biopsy and kidney transplantation	1.01	0.99–1.02	.14
Tacrolimus before switch or biopsy	0.48	0.17–1.33	.16
MMF before switch or biopsy	0.87	0.24–3.07	.82
Steroids before switch or biopsy	2.12	0.60–7.53	.24
MMF after switch or biopsy	1.50	0.34–6.67	.59
Steroids after switch or biopsy	1.51	0.56–2.23	.48
*Belatacept switch*	*6.31*	*1.42–27.95*	.01	*4.84*	*1.09–21.51*	.04
Rejection after switch or biopsy	1.50	0.34–6.71	.59
Cancer after switch or biopsy	2.48	0.79–7.80	.12

Varaibles	HR	95% CI	P-value	HR	95% CI	P-value
Age	1.08	1.02–1.14	.01	1.08	1.01–1.14	.02
Female	2.08	0.76–5.76	.15
ECD	1.13	0.40–3.20	.82
eGFR on day 0	0.94	0.87–1.01	.09	0.94	0.86–1.03	.15
Transplant department	1.15	0.41–3.25	.79
Interval between biopsy and kidney transplantation	1.01	0.99–1.02	.14
Tacrolimus before switch or biopsy	0.48	0.17–1.33	.16
MMF before switch or biopsy	0.87	0.24–3.07	.82
Steroids before switch or biopsy	2.12	0.60–7.53	.24
MMF after switch or biopsy	1.50	0.34–6.67	.59
Steroids after switch or biopsy	1.51	0.56–2.23	.48
*Belatacept switch*	*6.31*	*1.42–27.95*	.01	*4.84*	*1.09–21.51*	.04
Rejection after switch or biopsy	1.50	0.34–6.71	.59
Cancer after switch or biopsy	2.48	0.79–7.80	.12

Bold values are independent risk factors for opportunistic infections. Italicized values are statistically significant result in univariate analysis.

Table 6.

Open in new tab

Univariate and multivariate Cox analysis for determining factors associated with OPIs

Varaibles	HR	95% CI	P-value	HR	95% CI	P-value
Age	1.08	1.02–1.14	.01	1.08	1.01–1.14	.02
Female	2.08	0.76–5.76	.15
ECD	1.13	0.40–3.20	.82
eGFR on day 0	0.94	0.87–1.01	.09	0.94	0.86–1.03	.15
Transplant department	1.15	0.41–3.25	.79
Interval between biopsy and kidney transplantation	1.01	0.99–1.02	.14
Tacrolimus before switch or biopsy	0.48	0.17–1.33	.16
MMF before switch or biopsy	0.87	0.24–3.07	.82
Steroids before switch or biopsy	2.12	0.60–7.53	.24
MMF after switch or biopsy	1.50	0.34–6.67	.59
Steroids after switch or biopsy	1.51	0.56–2.23	.48
*Belatacept switch*	*6.31*	*1.42–27.95*	.01	*4.84*	*1.09–21.51*	.04
Rejection after switch or biopsy	1.50	0.34–6.71	.59
Cancer after switch or biopsy	2.48	0.79–7.80	.12

Varaibles	HR	95% CI	P-value	HR	95% CI	P-value
Age	1.08	1.02–1.14	.01	1.08	1.01–1.14	.02
Female	2.08	0.76–5.76	.15
ECD	1.13	0.40–3.20	.82
eGFR on day 0	0.94	0.87–1.01	.09	0.94	0.86–1.03	.15
Transplant department	1.15	0.41–3.25	.79
Interval between biopsy and kidney transplantation	1.01	0.99–1.02	.14
Tacrolimus before switch or biopsy	0.48	0.17–1.33	.16
MMF before switch or biopsy	0.87	0.24–3.07	.82
Steroids before switch or biopsy	2.12	0.60–7.53	.24
MMF after switch or biopsy	1.50	0.34–6.67	.59
Steroids after switch or biopsy	1.51	0.56–2.23	.48
*Belatacept switch*	*6.31*	*1.42–27.95*	.01	*4.84*	*1.09–21.51*	.04
Rejection after switch or biopsy	1.50	0.34–6.71	.59
Cancer after switch or biopsy	2.48	0.79–7.80	.12

Bold values are independent risk factors for opportunistic infections. Italicized values are statistically significant result in univariate analysis.